The toxic effect of NO in the setting of SAH could become even more significant because of the reactive overproduction of NO. The enzyme responsible for producing NO, nitric oxide synthase (NOS), is known to be present in a variety of cell types, including vascular endothelial cells, smooth-muscle cells, glial cells, and neurons. Nitric oxide synthase is classified into three isoforms: two types are constitutively expressed (cNOSs) in neurons and vascular endothelium. More recently, an additional isoform of NOS has been identified as inducible NOS (iNOS). 74 This isoform is induced by various inflammatory factors such as cytokines, lipopolysaccharides, hemoglobin breakdown products, and endotoxins. 1, 8, 11, 14, 20, 22, 23, 34, 40, 47, 59, 64, 65, 69, 71, 76 The properties of both constitutively expressed NOS isoforms, such as maintaining adequate tissue perfusion, 13, 27 are better known than the characteristics of the iNOS isoform. Endothelial NO overproduction would be expected as a physiological response to counteract vasospasm. Whether endothelial injury in SAH does block such a response is unknown at the present time. Our experiments were designed to investigate the response of iNOS, which appears to be responsible for the large-scale fluctuations in the NO pool.
Materials and Methods
Fifteen male Wistar rats, each weighing 250 to 300 g, were anesthetized by intraperitoneal injection of chloral hydrate (0.36 mg/100 g body weight). Monitoring of vital parameters, femoral arterial pressure, temperature, and arterial blood gas levels was established. After immobilization of each animal in a stereotactic frame, a small suboccipital incision was made for microsurgical exposure of the atlantooccipital membrane. The cisterna magna was tapped using a 25-gauge needle and 0.1 ml cerebrospinal fluid (CSF) was aspirated. The same syringe was used to withdraw 0.4 ml blood from the femoral artery, which was mixed with the CSF to prevent rapid coagulation. A 0.1-ml bolus of the blood-CSF mixture was injected into the cisterna magna. This technique resulted in an even blood distribution within the basal cisterns (Fig. 1) . Finally, the wound was closed and the animal was placed with its head facing downward for 5 minutes. The same procedure was repeated 24 hours later. A control group of 10 animals was treated with injections of a 0.9% sodium chloride solution. Eight days after the first experimental SAH, the animals were reanesthetized. The external carotid artery (ECA) was exposed for retrograde cannulation and pressurecontrolled angiography. Middle cerebral artery (MCA) diameters were measured on enlarged radiographs. By using the retrograde ECA technique, the extracranial stapedial artery was also visualized on the radiographs. The vessel projection was used as a technical quality control for the angiography.
The rats were fixed by intracardiac perfusion with 1% glutaraldehyde and their brains were removed for immunohistochemical assessment. Free-floating coronal cryosections (40 m) were incubated with a primary monoclonal mouse antibody against iNOS (Transduction Laboratories, Lexington, KY). Using a kit (Vecta Stain Elite kit; Vector Laboratories, Burlingame, CA), the sections were stained with diaminobenzidine tetrahydrochloride and counterstained with hematoxylin. Sections were mounted every 400 m for microscopic analysis. The immunohistochemical staining was assessed in a blinded fashion by independent observers and classified as intensive, moderate, or poor. Assessment of staining intensity was based on the internal carotid artery (ICA), MCA, basilar artery, and basal surface of the brain. The angiographic results were compared with the intensity of the immunohistochemical staining. Statistical analysis was performed using the Whitney-Mann-Wilcoxon test. Values are shown as the mean Ϯ standard deviation. (Fig. 2) . Clear angiographic vasospasm was seen in 11 of 15 animals with SAH (Fig. 3) . In four animals with experimental SAH, no vasospasm was found. The diameter of the MCA in the experimental group was 0.3 Ϯ 0.08 mm compared with 0.4 Ϯ 0.03 mm in the control group. This 25% reduction in vessel diameter was significant when the Whitney-Mann-Wilcoxon test was applied: p Ͻ 0.005.
Results

During
Microscopic analysis of sections in the experimental group revealed intense staining in eight vasospastic brains (Fig. 4) . Within the resolution of the qualitative assessment, no differences in staining intensity could be identified among the ICA, MCA, basilar artery, and basal surface of the brain. Staining was moderate in three brains with angiographic evidence of vasospasm. Poor staining was observed in the four experimental animals that had no radiographic signs of vasospasm, as well as in all 10 control brains (Fig. 5) . Labeling of iNOS could primarily be traced in endothelial cells, vascular smooth-muscle cells, and, above all, in adventitial cells. Some labeling was also observed in rod cells, glial networks, and neurons.
Discussion
Regarding the importance of NO, most recent reports postulate decreased levels of endothelial NO or decreased efficacy of this mediator as the main cause of vasospasm. 3, 24, 25, 29, 33, 48, 57, 69, 75 In general these results were drawn on the basis of the effect of NO agonists and antagonists in experimental vasospasm. There is little information on direct assessments of cNOS and iNOS levels after SAH. Apart from the present study, Hino and coworkers 24 demonstrated decreased endothelial NOS messenger RNA after experimental SAH in monkeys, and Pluta and colleagues 57 described decreased NOS immune reactivity in vasospastic cerebral arteries of primates. Both reports address the physiological vascular tone-modulating cNOS. The iNOS isoform has been neglected until recently, when Tanazawa, et al., 69 suspected that induction of iNOS might be an important factor after SAH in counteracting vasospasm. These authors provided indirect evidence that induction of iNOS may be less effective in dogs exhibiting severe vasospasm after experimental SAH.
Nitric oxide appears to be a major source of oxidative free radicals. In previous experiments our group 45 demonstrated that the NO metabolite peroxynitrite is associated with vasospasm after experimental SAH in rats. We concluded that peroxidation damage to membrane proteins is a significant factor in the chronic form of vasospasm. In line with this result is the report by Kajita, et al., 29 who demonstrated that administration of superoxide dismutase could attenuate vasospasm after SAH in dogs. Superoxide dismutase protected the NO molecules from oxidation by superoxide anion. Similarly, Kwan, et al., 38 showed in a cell culture model that free radical generation and lipid peroxidation are critical participants in hemolysate-induced endothelial injury and that NO is the most likely source of peroxidative damage. The present experiments demonstrate widespread induction of iNOS after experimental SAH. This induction may be understood as a feedback control mechanism to counteract vasospasm. 56 Induction of iNOS is known to be a nonspecific reaction to a variety of stimuli. 62 Because reactive overproduction also generates free radicals, this feedback-controlled or nonspecific response may be considered a vicious circle, leading to progressive vascular damage.
In our experiments iNOS was found in endothelial cells, in smooth-muscle cells and, above all, in adventitial cells. Occasional labeling of iNOS was observed in rod cells (activated microglia) and in glial networks. Other authors have described an identical location of the iNOS isoform in other experimental settings. 6, 11, 20, 23, 47, 52, 63 The distribution of iNOS in the present experiments corresponds to the distribution of peroxynitrite, as demonstrated in previous studies. 5 This conformity supports the concept that iNOS is the most prominent source of this pathological and toxic NO reaction product.
In the present study and in others reported in the literature, vasospastic vessels showed a relatively normal number of endothelial cells. At the same time these cells exhibited features of structural damage: pathological vacuolation, loss of tight junctions, and wall necrosis. 18, 43, 44 These pathological phenomena support the concept of a toxic factor. The present results showed a positive correlation between induction of iNOS and the degree of vasospasm. The correlation does not imply causality, but vasospasm and iNOS induction may be independent sequelae of small experimental variations such as the amount of clot. That iNOS induction is the cause of vasospasm could be proved by successful suppression of vasospasm by iNOS antagonists. On the other hand, absence of such a preventive effect of iNOS antagonists would not prove that there is no causal relationship between iNOS induction and vasospasm because these antagonists might interfere with the NO level necessary for physiological dilatative tone.
Several studies have demonstrated that the inflammatory cytokines mediate induction of iNOS in glial cells. 8, 46, 51, 67 These reports on the potential inflammatory induction of iNOS after SAH generated therapeutic attempts with corticosteroid medications. It has already been reported that high doses of steroids inhibit the synthesis of cytokines and iNOS. 34, 55, 59 Some steroid medications are also known to be potent scavengers of oxygen free radicals and inhibitors of lipid peroxidation. 30 However, thus far clinical results are less conclusive. 31 In view of our findings, a most promising new therapeutic strategy might be treatment using specific or nonspecific iNOS inhibitors in combination with other vascular relaxants. 17, 61 Experimental trials with NOS antagonists have been performed in experimental ischemia. The inhibition of NOS showed positive effects in some studies, but not in others. 28, 73 With regard to SAH, potential effects of NO antagonists are multiple and first need to be evaluated experimentally.
Conclusions
Seven days after experimental SAH was induced in rats, a significant increase in the iNOS isoform was observed in endothelial cells, smooth-muscle cells, adventitial cells, and glial networks. This distribution corresponds to the distribution of the toxic NO reaction product peroxynitrite.
